This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

AI x Next Generation Clinical Trials
April 22-23, 2026
Sheraton Boston HotelBoston, MA

Dustin Vondau, PhD
Senior Medical Writer at Merck
Speaker

Profile

Dustin Vondau is currently a disclosure medical writer for Merck Sharp and Dohme LLC with over 9 years of broad experience in clinical trials. He has a PhD in molecular genetics and microbiology from Duke University, entered clinical research as a clinical research associate, then became a medical writer drafting public disclosure documents primarily for ClinicalTrials.gov and EudraCT/CTIS. He has worked on multiple medical writing projects related to AI and continues to look for new opportunities where AI can be developed for the Merck team.

Agenda Sessions

  • Panel: Intelligent Documentation: AI for Medical Writing and Reporting

    4:45pm